Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 336

1.

Long-lasting T cell responses to biological warfare vaccines in human vaccinees.

Allen JS, Skowera A, Rubin GJ, Wessely S, Peakman M.

Clin Infect Dis. 2006 Jul 1;43(1):1-7. Epub 2006 May 23.

2.

Analysis of anthrax and plague biowarfare vaccine interactions with human monocyte-derived dendritic cells.

Skowera A, de Jong EC, Schuitemaker JH, Allen JS, Wessely SC, Griffiths G, Kapsenberg M, Peakman M.

J Immunol. 2005 Dec 1;175(11):7235-43.

3.

Plasmid-based vaccination with candidate anthrax vaccine antigens induces durable type 1 and type 2 T-helper immune responses.

Zhang Y, Qiu J, Zhou Y, Farhangfar F, Hester J, Lin AY, Decker WK.

Vaccine. 2008 Jan 30;26(5):614-22. doi: 10.1016/j.vaccine.2007.11.072. Epub 2007 Dec 18.

PMID:
18166249
4.

[The time course of changes in cell immunological parameters during administration of live dry plague vaccine].

Bogacheva NV, Darmov IV, Borisevich IV, Kriuchkov AV, Pechenkin DV.

Klin Lab Diagn. 2009 Aug;(8):24-7. Russian.

PMID:
19827193
5.

Immunological responses are not abnormal in symptomatic Gulf War veterans.

Everson MP, Shi K, Aldridge P, Bartolucci AA, Blackburn WD.

Ann N Y Acad Sci. 2002 Jun;966:327-42. Review.

PMID:
12114290
6.

Activation of cell-mediated immunity following immunization with pneumococcal conjugate or polysaccharide vaccine.

Wuorimaa T, Käyhty H, Eskola J, Bloigu A, Leroy O, Surcel HM.

Scand J Immunol. 2001 Apr;53(4):422-8.

7.
8.

Natural exposure to cutaneous anthrax gives long-lasting T cell immunity encompassing infection-specific epitopes.

Ingram RJ, Metan G, Maillere B, Doganay M, Ozkul Y, Kim LU, Baillie L, Dyson H, Williamson ED, Chu KK, Ascough S, Moore S, Huwar TB, Robinson JH, Sriskandan S, Altmann DM.

J Immunol. 2010 Apr 1;184(7):3814-21. doi: 10.4049/jimmunol.0901581. Epub 2010 Mar 5.

9.
10.

Immunological dynamics in response to two anthrax vaccines in mice.

Lü J, He R, Dong M, Zhang L, Wang X.

Sci China C Life Sci. 2008 Oct;51(10):872-8. doi: 10.1007/s11427-008-0119-4. Epub 2008 Sep 26.

PMID:
18815750
11.

Generalized cutaneous reactions to the anthrax vaccine: preliminary results of anthrax vaccine-specific cell mediated immunity and cytokine profiles.

Parker AL, England RW, Nguyen SA, Whisman BA, Hagan LL.

Hum Vaccin. 2006 May-Jun;2(3):105-9. Epub 2006 May 4.

PMID:
17012907
12.

Unconventional cytokine profiles and development of T cell memory in long-term survivors after cancer vaccination.

Kyte JA, Trachsel S, Risberg B, thor Straten P, Lislerud K, Gaudernack G.

Cancer Immunol Immunother. 2009 Oct;58(10):1609-26. doi: 10.1007/s00262-009-0670-2. Epub 2009 Feb 17.

PMID:
19221745
13.

Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.

Vandepapelière P, Horsmans Y, Moris P, Van Mechelen M, Janssens M, Koutsoukos M, Van Belle P, Clement F, Hanon E, Wettendorff M, Garçon N, Leroux-Roels G.

Vaccine. 2008 Mar 4;26(10):1375-86. doi: 10.1016/j.vaccine.2007.12.038. Epub 2008 Jan 14.

PMID:
18272264
14.

Investigation in a model system of the effects of combinations of anthrax and pertussis vaccines administered to service personnel in the 1991 Gulf War.

Rijpkema SG, Adams T, Rigsby P, Xing DK, Corbel MJ.

Hum Vaccin. 2005 Jul-Aug;1(4):165-9. Epub 2005 Jul 1.

PMID:
17012879
15.

Genetic immunization with GPI-anchored anthrax protective antigen raises combined CD1d- and MHC II-restricted antibody responses by natural killer T cell-mediated help.

Midha S, Bhatnagar R.

Vaccine. 2009 Mar 10;27(11):1700-9. doi: 10.1016/j.vaccine.2009.01.042. Epub 2009 Feb 3.

PMID:
19195490
16.

Newly described cell type may prove valuable in development of plague vaccines against biowarfare.

[No authors listed]

Expert Rev Vaccines. 2011 Mar;10(3):259. doi: 10.1586/erv.11.19. No abstract available.

PMID:
21434794
17.

[Novel vaccines against M. tuberculosis].

Okada M.

Kekkaku. 2006 Dec;81(12):745-51. Review. Japanese.

PMID:
17240920
18.

TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis: role of IL-17-producing T cells.

Higgins SC, Jarnicki AG, Lavelle EC, Mills KH.

J Immunol. 2006 Dec 1;177(11):7980-9.

19.

[The experimental evaluation with flow cytofluorimetry technique of the level of cellular immunologic memory in persons vaccinated against plague and anthrax].

Bogacheva NV, Kriuchkov AV, Darmov IV, Vorob'ev KA, Pechenkin DV, Elagin GD, Kolesnikiov DP.

Klin Lab Diagn. 2013 Nov;(11):48-53. Russian.

PMID:
24640112
20.

Soluble CD30 and lymphocyte activation gene-3 (CD223), as potential serological markers of T helper-type cytokine response induced by acellular pertussis vaccine.

Ausiello CM, Palazzo R, Spensieri F, Urbani F, Massari M, Triebel F, Benagiano M, D'Elios MM, Del Prete G, Cassone A.

Int J Immunopathol Pharmacol. 2006 Jan-Mar;19(1):97-104.

PMID:
16569347
Items per page

Supplemental Content

Write to the Help Desk